Effectiveness and safety in Crohn's disease patients who were treated with CT-P13

被引：0
|
作者：
Choe, Y. H. [1 ]
Lee, S. -H. [2 ]
Park, D. I. [3 ]
Lee, J. H. [4 ]
Kim, H. J. [5 ]
Kim, Y. -H. [6 ]
Choi, C. H. [7 ]
Eun, C. S. [8 ]
Lee, S. J. [9 ]
Lee, S. [9 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Dept Pediat, Samsung Med Ctr, Seoul, South Korea
[2] Esoo Hosp, Digest Endoscop Ctr, Cheonan Si, South Korea
[3] Kangbuk Samsung Hosp, Dept Internal Med, Seoul, South Korea
[4] Seoul Song Do Colorectal Hosp, Dept Internal Med, Seoul, South Korea
[5] Kyung Hee Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[6] Sungkyunkwan Univ, Sch Med, Dept Internal Med, Samsung Med Ctr, Seoul, South Korea
[7] Chung Ang Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[8] Hanyang Univ, Coll Med, Dept Internal Med, Guri Hosp, Guri, South Korea
[9] CELLTRION Inc, Incheon, South Korea
来源：
JOURNAL OF CROHNS & COLITIS | 2017年 / 11卷
关键词：
INFLIXIMAB;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P500
引用
收藏
页码：S333 / S333
页数：1
相关论文
共 50 条
  • [31] 5 year budget impact analysis of CT-P13 (Infliximab) for the treatment of Crohn's Disease in UK, Italy and France
    Kim, J.
    Hong, J. An
    Kudrin, A.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S144 - S145
  • [32] Switching to biosimilar infliximab (CT-P13): Evidence of clinical safety, effectiveness and impact on public health
    Braun, Juergen
    Kudrin, Alex
    BIOLOGICALS, 2016, 44 (04) : 257 - 266
  • [33] Infliximab-Biosimilar CT-P13 Phase-III-Study confirms Non-Inferiority for Reference in Patients with Crohn's Disease
    不详
    VISCERAL MEDICINE, 2019, 35 (03) : 198 - 198
  • [34] EFFECTIVENESS AND SAFETY OF BIOSIMILAR INFLIXIMAB (CT-P13) IN A REAL-LIFE SETTING IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Codreanu, C.
    Sirova, K.
    Jarosova, K.
    Batalov, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 489 - 489
  • [35] EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF SWITCHING FROM ORIGINATOR INFILIXIMAB TO BIOSIMILAR INFLIXIMAB (CT-P13) IN A LARGE COHORT OF IBD PATIENTS
    Privitera, Giuseppe
    Pugliese, Daniela
    Tolusso, Barbara
    Gremese, Elisa
    Papa, Alfredo
    Papparella, Luigi Giovanni
    Gasbarrini, Antonio
    Rapaccini, Gian Lodovico
    Guidi, Luisa
    Armuzzi, Alessandro
    GASTROENTEROLOGY, 2020, 158 (06) : S462 - S462
  • [36] EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF SWITCHING FROM ORIGINATOR INFILIXIMAB TO BIOSIMILAR INFLIXIMAB (CT-P13) IN A LARGE COHORT OF IBD PATIENTS
    Privitera, G.
    Pugliese, D.
    Tolusso, B.
    Gremese, E.
    Papa, A.
    Papparella, L. G.
    Gasbarrini, A.
    Rapaccini, G. L.
    Guidi, L.
    Armuzzi, A.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : S10 - S11
  • [37] Infliximab biosimilar CT-P13 for inflammatory bowel disease
    Bonovas, Stefanos
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (06): : 373 - 375
  • [38] SAFETY AND EFFICACY OF INFLIXIMAB BIOSIMILAR SB2 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE WHO UNDERWENT A SWITCH FROM INFLIXIMAB BIOSIMILAR CT-P13
    Lovero, R.
    Losurdo, G.
    Biscaglia, G.
    Valvano, M. R.
    Biancofiore, A.
    Martino, G.
    Nardella, M.
    Andriulli, A.
    Principi, M.
    Bossa, F.
    DIGESTIVE AND LIVER DISEASE, 2019, 51 : E227 - E227
  • [39] Safety and effectiveness of ustekinumab in elderly Crohn's disease patients
    Fiske, Joseph
    Liu, Eleanor
    Limdi, Jimmy K.
    Conley, Thomas E.
    Townsend, Tristan
    Davies, Mike
    Brockwell, Robert
    Baig, Daniyal
    Abdelbadiee, Sherif
    Uney, Anastasia
    Liaros, Angela
    Gaba, Waqas
    Smith, Philip J.
    Flanagan, Paul K.
    Subramanian, Sreedhar
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (11) : 1132 - 1139
  • [40] Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months (vol 62, pg 1305, 2017)
    Arguelles-Arias, F.
    Guerra Veloz, M. F.
    Perea Amarillo, R.
    Vilches-Arenas, A.
    Castro Laria, L.
    Maldonado Perez, B.
    Chaaro, D.
    Benitez Roldan, A.
    Merino, V.
    Ramirez, G.
    Caunedo Alvarez, A.
    Romero-Gomez, Manuel
    DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (08) : 2203 - 2203
12345